Your browser doesn't support javascript.
loading
Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al.
Ikeda, M; Shimizu, S; Sato, T; Morimoto, M; Kojima, Y; Inaba, Y; Hagihara, A; Kudo, M; Nakamori, S; Kaneko, S; Sugimoto, R; Tahara, T; Ohmura, T; Yasui, K; Sato, K; Ishii, H; Furuse, J; Okusaka, T.
Afiliação
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Shimizu S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sato T; Department of Biostatistics, Kyoto University School of Public Health, Kyoto, Japan.
  • Morimoto M; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kojima Y; Department of Gastroenterology, National Center for Global Health and Medicine Center Hospital, Tokyo, Japan.
  • Inaba Y; Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hagihara A; Department of Hepatology, Osaka City University Hospital, Osaka, Japan.
  • Kudo M; Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
  • Nakamori S; Department of Hepatobiliary and Pancreatic Surgery, Osaka National Hospital, Osaka, Japan.
  • Kaneko S; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
  • Sugimoto R; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Tahara T; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
  • Ohmura T; Department of Gastroenterology, Sapporo Kosei General Hospital, Sapporo, Japan.
  • Yasui K; Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Sato K; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
  • Ishii H; Clinical Research Center, Shikoku Cancer Center, Matsuyama, Japan.
  • Furuse J; Department of Medical Oncology, Kyorin University, Tokyo, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ann Oncol ; 28(4): 903-904, 2017 04 01.
Article em En | MEDLINE | ID: mdl-28137738
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Carcinoma Hepatocelular Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Carcinoma Hepatocelular Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão